50 results on '"Chinnaswamy, Krishnapriya"'
Search Results
2. Discovery of SD-436: A Potent, Highly Selective and Efficacious STAT3 PROTAC Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression.
3. Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity
4. Changing the Apoptosis Pathway through Evolutionary Protein Design
5. CSAR data set release 2012: ligands, affinities, complexes, and docking decoys.
6. Prophylactic Mitigation of Acute Graft versus Host Disease by Novel 2-(Pyrrolidin-1-ylmethyl)pyrrole-Based Stimulation-2 (ST2) Inhibitors
7. Correction to “Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) Domains”
8. Profiling the Binding Activities of Peptides and Inhibitors to the U2 Auxiliary Factor Homology Motif (UHM) Domains
9. Novel Chemical Series of Anti-ST2 Small Molecules Suppress Allogeneic T Cells Proliferation While Increasing Treg Cells and Improve Gvhd and Survival In Vivo
10. Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding
11. Structure-Activity Relationship of 1-(Furan-2ymethyl)Pyrrolidinebbased Stimulation-2 (ST2) Inhibitors for Treating Graft Versus Host Disease
12. Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
13. Effects of age and retinal degeneration on the expression of proprotein convertases in the visual cortex
14. Discovery of EEDi-5273 as an Exceptionally Potent and Orally Efficacious EED Inhibitor Capable of Achieving Complete and Persistent Tumor Regression
15. Discovery of M-1121 as an Orally Active Covalent Inhibitor of Menin-MLL Interaction Capable of Achieving Complete and Long-Lasting Tumor Regression
16. Small-Molecule U2 Auxiliary Factor Homology Motif (UHM) Domain Inhibitors Cause Splicing Pattern Changes in U2AF1 Mutant Leukemia Cells and Induce Sub-G1 Cell Cycle Arrest
17. SD-91 as A Potent and Selective STAT3 Degrader Capable of Achieving Complete and Long-Lasting Tumor Regression
18. Abstract LB-226: Discovery of small molecule Mcl-1 and Bfl-1 inhibitors
19. EEDi-5285: An Exceptionally Potent, Efficacious, and Orally Active Small-Molecule Inhibitor of Embryonic Ectoderm Development
20. Discovery of M-808 as a Highly Potent, Covalent, Small-Molecule Inhibitor of the Menin–MLL Interaction with Strong In Vivo Antitumor Activity
21. Discovery and Characterization of 2,5-Substituted Benzoic Acid Dual Inhibitors of the Anti-apoptotic Mcl-1 and Bfl-1 Proteins
22. Computational Cosolvent Mapping Analysis Leads to Identify Salicylic Acid Analogs as Weak Inhibitors of ST2 and IL33 Binding.
23. Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands
24. Structure-Based Discovery of SD-36 as a Potent, Selective, and Efficacious PROTAC Degrader of STAT3 Protein
25. A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
26. Structure-Based Discovery of M-89 as a Highly Potent Inhibitor of the Menin-Mixed Lineage Leukemia (Menin-MLL) Protein–Protein Interaction
27. Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER)
28. Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer
29. Discovery of ST2 Inhibitors: From Biomarker to Potential Drug Target in Graft-Versus-Host Disease
30. From proteomics to discovery of first-in-class ST2 inhibitors active in vivo
31. High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein–Protein Interaction
32. Design of the First‐in‐Class, Highly Potent Irreversible Inhibitor Targeting the Menin‐MLL Protein–Protein Interaction
33. Inhibition of Biomarker ST2 by Small Molecules Improves Survival in Allogeneic Hematopoietic Cell Transplantation
34. A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation
35. Discovery of AK-1690: A Potent and Highly Selective STAT6 PROTAC Degrader
36. High-Affinity Peptidomimetic Inhibitors of the DCN1-UBC12 Protein–Protein Interaction
37. Small Molecule ST2 Inhibitors Cause Reduction of Soluble ST2 and Improve Gvhd and Survival In Vivo
38. Mechanistic evaluation and transcriptional signature of a glutathione S-transferase omega 1 inhibitor
39. Buried Hydrogen Bond Interactions Contribute to the High Potency of Complement Factor D Inhibitors
40. Conformational Sampling and Binding Site Assessment of Suppression of Tumorigenicity 2 Ectodomain
41. Small-Molecule U2 Auxiliary Factor Homology Motif (UHM) Domain Inhibitors Cause Splicing Pattern Changes in U2AF1Mutant Leukemia Cells and Induce Sub-G1 Cell Cycle Arrest
42. CSAR Benchmark Exercise 2013: Evaluation of Results from a Combined Computational Protein Design, Docking, and Scoring/Ranking Challenge
43. Abstract LB-058: Novel interactions of the RAS oncoprotein
44. Structure-Based Design of γ-Carboline Analogues as Potent and Specific BET Bromodomain Inhibitors
45. A potent small-molecule inhibitor of the DCN1-UBC12 interaction that selectively blocks cullin 3 neddylation.
46. Discovery of ARD-69 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Androgen Receptor (AR) for the Treatment of Prostate Cancer
47. CSAR Benchmark Exercise 2013: Evaluation of Results from a Combined Computational Protein Design, Docking, and Scoring/Ranking Challenge.
48. CSAR Data Set Release 2012: Ligands, Affinities, Complexes,and Docking Decoys.
49. Effects of Age and Retinal Degeneration on the Expression of Subtilisin-like Proprotein Convertases in the Visual Cortex of Mice
50. Comprehensive Analyses of the Effects of the Small-Molecule Inhibitor of the UHM Domain in the Splicing Factor U2AF1 in Leukemia Cells.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.